|
|
| Possess state-of-the-Art manufacturing facilities for finished Dosage Forms & API's conforming to the most Stringent International Norms WHO-GMP, TGA (Australia), MHRA (UK).
|
Manufacturing capacity (Finished Dosage) :
 2300 million Tablets- 64 million Ampoules
- 27 million Vials
- 84 million Capsules
- 18 million Dermatological products
- 62 million Oral liquid bottles
|
Manufacturing capacity (API) :
- 1,50,0000 (15 lakhs) sq. ft. covered area
- 11 Dedicated blocks operating as per USFDA guidelines.
- 700 Stainless Steel and Glass Lined Reaction Vessels with capacities ranging from 50 to 6000 liters. (Total Volume 1000 kilo liters).
- 3 Automated Fluidized bed coaters with capacity of manufacturing 4 Metric tonn of Granules per month.
- CGMP pilot plant having 10 reaction vessels with capacities ranging from 250 to 1000 liters( Total volume 5.5 kilo-liters)
- Fully Automated Solvent Recovery System
- Biological waste water treatment plant.
- Approvals from TGA (Australia), USFDA, WHO-GMP, MHRA(UK),NDA (Uganda),TFDA(Tanzania),UAEC, DACA-(Ethiopia),GMP(Yemen)
- R & D facility duly approved by department of Science of Technology, Govt of India. With Dedicated facility with eight synthetic labs over 40,000 Sq ft research area with best pool of scientists & researchers.
|
|
